Birdwatch Note Rating
2024-01-23 02:07:19 UTC - NOT_HELPFUL
Rated by Participant: 6B3D363FE5A4A6410FE95AF7DB02DB5F83EB64C37321AB3F4618CD7630887EF7
Participant Details
Original Note:
This news, from November, pertains to a gene therapy treatment for a type of cancer (not COVID-19). The FDA press release specifically notes the benefits of the treatment continue to outweigh the risks. https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/fda-investigating-serious-risk-t-cell-malignancy-following-bcma-directed-or-cd19-directed-autologous
All Note Details